Whalesbook
Omaxe Group has successfully raised ₹75 crore from WSB Partners, earmarked for its residential plotted projects in Ujjain and Indore. This funding round suggests growing investor confidence in Tier II cities, fueled by economic expansion and better infrastructure.
Sun Pharma Advanced Research Company (SPARC) faced a significant setback when its licensing partner, OcuVex Therapeutics, received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for the glaucoma drug PDP-716. The FDA's decision was based on manufacturing inspection issues at a third-party facility, not on concerns regarding the drug's efficacy or safety.
JSW Energy plans to increase its stake in Toshiba JSW Power Systems (TJPS) to 20.7% by purchasing shares from Toshiba Corporation for ₹150 crore. This move aims to improve access to steam turbine generators and enhance supply chain resilience as the company targets a capacity of 30 GW by FY2030.
Jindal (India) Ltd. has completed a ₹1,500-crore capital expenditure program in West Bengal, which includes a new high-speed continuous colour coating line. This expansion is expected to significantly increase its coated flat-steel product output, potentially boosting revenue by 75% in FY27, with production capacity reaching 60,000 tonnes per month.
ITC has raised its shareholding in Mother Sparsh Baby Care to 49.32% through a ₹30 crore secondary purchase, aligning with its strategy to build a portfolio of future-ready products. Mother Sparsh saw its turnover grow from ₹58.7 crore in 2023-24 to ₹138.5 crore in 2025-26.
Automotive component maker Remsons Industries announced that its subsidiary, Remsons Automotive (UK), secured a six-year contract worth approximately ₹30 crore for supplying Hood Rods. Additionally, Airfloa Rail Technology received a ₹2.68 crore order from Integral Coach Factory, Chennai, for panelling for railway coaches.
The National Company Law Appellate Tribunal (NCLAT) ruled in favor of Lyka Labs, ordering Modi Lifecare Industries to pay ₹63 lakh within 30 days to avoid insolvency proceedings, overturning a previous order.
Transformers and Rectifiers (India) Ltd. was awarded a ₹175 crore order from Bhanwariya Infra Projects for transformers and reactors, with deliveries slated by March 2028.
Mastek, a digital engineering firm, has appointed Amit Gajwani as its new Chief Operating Officer.
SPARC's situation underscores the significant risks associated with pharmaceutical development and regulatory approvals, particularly the reliance on third-party manufacturing. Such dependencies can lead to substantial delays and financial losses, impacting market entry timelines and investor sentiment, even when the drug's clinical profile remains strong. Resolution of these manufacturing issues is crucial for SPARC's future approvals and revenue generation.
Overall, these corporate updates reflect a varied investor sentiment across different sectors. While Omaxe's funding indicates ongoing interest in real estate, especially in smaller cities, SPARC's challenge serves as a reminder of the pharmaceutical industry's complexities. Meanwhile, strategic investments by JSW Energy and ITC suggest established companies are consolidating their positions and focusing on long-term growth.